The 180 seconds TV Documentary which featured the leadership of the Ghana Health Service and the National Malaria Control Program was produced to encourage prescribers adhere to the WHO Test Treat and Track protocols. RDT Kits at community level facilities and local pharmacies hold the key to making testing widely available most of the time, as less than half of the Laboratories in Ghana were open 7 days a week; only one third were open 24 hours a day, leaving many patients without access to diagnostic services when they might need them.

Results of a stage three trial after 18 months of follow up show that RTS,S almost halved the number of malaria cases in young children (aged 5-17 months at first vaccination) and reduced by around a quarter the malaria cases in infants (aged 6-12 weeks at first vaccination). Eleven African research centres in seven African countries are conducting this trial, together with GlaxoSmithKline (GSK) and the PATH Malaria Vaccine Initiative (MVI), with grant funding from the Bill & Melinda Gates Foundation to Malaria Vaccine Initiative (MVI).